212 related articles for article (PubMed ID: 35197460)
1. Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice.
Gao H; Zhou L; Zhong Y; Ding Z; Lin S; Hou X; Zhou X; Shao J; Yang F; Zou X; Cao H; Xiao G
Nat Commun; 2022 Feb; 13(1):1025. PubMed ID: 35197460
[TBL] [Abstract][Full Text] [Related]
2. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
[TBL] [Abstract][Full Text] [Related]
3. Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through β-catenin/Foxo1/TLR4 signaling.
Qian LL; Ji JJ; Jiang Y; Guo JQ; Wu Y; Yang Z; Ma GS; Yao YY
FASEB J; 2022 May; 36(5):e22316. PubMed ID: 35429042
[TBL] [Abstract][Full Text] [Related]
4. p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling.
Kundu D; Kennedy L; Zhou T; Ekser B; Meadows V; Sybenga A; Kyritsi K; Chen L; Ceci L; Wu N; Wu C; Glaser S; Carpino G; Onori P; Gaudio E; Alpini G; Francis H
Hepatology; 2023 Jul; 78(1):243-257. PubMed ID: 36799449
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
6. Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1.
Wang S; Liu T; Sun L; Du H; Xu Z; Li R; Yu Y; Mao Y; Shi K
Mol Cell Biochem; 2022 May; 477(5):1555-1568. PubMed ID: 35182330
[TBL] [Abstract][Full Text] [Related]
7. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
8. Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways.
Sabir U; Irfan HM; Alamgeer ; Umer I; Niazi ZR; Asjad HMM
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):741-755. PubMed ID: 35357518
[TBL] [Abstract][Full Text] [Related]
9. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice.
Yu CJ; Wang QS; Wu MM; Song BL; Liang C; Lou J; Tang LL; Yu XD; Niu N; Yang X; Zhang BL; Qu Y; Liu Y; Dong ZC; Zhang ZR
Hepatology; 2018 Nov; 68(5):1769-1785. PubMed ID: 29704259
[TBL] [Abstract][Full Text] [Related]
10. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
11. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway.
Wu H; Jin M; Han D; Zhou M; Mei X; Guan Y; Liu C
Biochem Biophys Res Commun; 2015 Mar; 458(4):862-8. PubMed ID: 25701781
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL).
Chen G; Yu D; Nian X; Liu J; Koenig RJ; Xu B; Sheng L
Sci Rep; 2016 Oct; 6():35531. PubMed ID: 27759039
[TBL] [Abstract][Full Text] [Related]
15. Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2.
Gao H; Guo Y; Yan Q; Yang W; Li R; Lin S; Bai X; Liu C; Chen D; Cao H; Xiao G
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292295
[TBL] [Abstract][Full Text] [Related]
16. Involvement of kindlin-2 in irisin's protection against ischaemia reperfusion-induced liver injury in high-fat diet-fed mice.
Zhang J; Ren Y; Bi J; Wang M; Zhang L; Wang T; Wei S; Mou X; Lv Y; Wu R
J Cell Mol Med; 2020 Nov; 24(22):13081-13092. PubMed ID: 32954626
[TBL] [Abstract][Full Text] [Related]
17. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
[TBL] [Abstract][Full Text] [Related]
18. Derlin-1 ameliorates nonalcoholic hepatic steatosis by promoting ubiquitylation and degradation of FABP1.
You H; Wen X; Wang X; Zhu C; Chen H; Bu L; Zhang J; Qu S
Free Radic Biol Med; 2023 Oct; 207():260-271. PubMed ID: 37499886
[TBL] [Abstract][Full Text] [Related]
19. Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice.
Zhu JY; Chen M; Mu WJ; Luo HY; Guo L
Metabolism; 2022 Sep; 134():155241. PubMed ID: 35750235
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
Nie H; Song C; Wang D; Cui S; Ren T; Cao Z; Liu Q; Chen Z; Chen X; Zhou Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3087-3094. PubMed ID: 28951211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
